Quantitative Prediction of Human Pharmacokinetics and Pharmacodynamics of CKD519, a Potent Inhibitor of Cholesteryl Ester Transfer Protein (CETP)

Quantitative Prediction of Human Pharmacokinetics and Pharmacodynamics of CKD519, a Potent Inhibitor of Cholesteryl Ester Transfer Protein (CETP)

CKD519, a selective inhibitor of cholesteryl ester transfer protein(CETP), is undergoing development as an oral agent for the treatment of primary hypercholesterolemia and mixed hyperlipidemia. The aim of this study was to predict the appropriate efficacious dose of CKD519 for humans in terms of the...

Full description

Bibliographic Details
Main Authors:	Suein Choi, Seunghoon Han, Sangil Jeon, Dong-Seok Yim
Format:	Article
Language:	English
Published:	MDPI AG 2019-07-01
Series:	Pharmaceutics
Subjects:	CETP inhibition dyslipidemia cholesteryl ester transfer protein pharmacodynamics pharmacokinetics in vivo-in vitro extrapolation (IVIVE) first-in-human allometric scaling prediction
Online Access:	https://www.mdpi.com/1999-4923/11/7/336

Similar Items

Pharmacokinetics, pharmacodynamics and safety of CKD-519, a CETP inhibitor, in healthy subjects
by: Kim CO, et al.
Published: (2016-11-01)

A Population Pharmacokinetic and Pharmacodynamic Model of CKD-519
by: Choon Ok Kim, et al.
Published: (2020-06-01)

A Molecular and Biochemical Study for Cholesteryl Ester Transfer Protein (CETP) Taq1B in Iraqi Patients with Hyperlipidemia
by: Alkhafajy et al.
Published: (2019-09-01)

Amyloidogenic Properties of a D/N Mutated 12 Amino Acid Fragment of the C-Terminal Domain of the Cholesteryl-Ester Transfer Protein (CETP)
by: Victor García-González, et al.
Published: (2011-03-01)

Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen
by: Ioannis Loisios-Konstantinidis, et al.
Published: (2020-11-01)

Study of Cholesteryl Ester Transfer Protein (CETP) I405v Genotype and Its Association with Lipid Fractions in Myocardial Infarction Patients: A Case Control Study
by: Prakash D. Zende, et al.
Published: (2014-06-01)

TaqI B1/B2 and -629A/C cholesteryl ester transfer protein (CETP) gene polymorphisms and their association with CETP activity and high-density lipoprotein cholesterol levels in a Tehranian population. Part of the Tehran Lipid and Glucose Study (TLGS)
by: Maryam S Daneshpour, et al.
Published: (2007-01-01)

Cholesteryl ester transfer protein (CETP), HDL capacity of receiving cholesterol and status of inflammatory cytokines in patients with severe heart failure
by: Ana Elisa M. Martinelli, et al.
Published: (2018-10-01)

Mechanism of inhibition defines CETP activity: a mathematical model for CETP in vitro
by: Laura K. Potter, et al.
Published: (2009-11-01)

Cholesteryl ester transfer protein:Ace of Spades, Queen of Hearts, or The Joker?
by: Norman Eric Miller
Published: (2015-07-01)

Association between Eight Functional Polymorphisms and Haplotypes in the Cholesterol Ester Transfer Protein (CETP) Gene and Dyslipidemia in National Minority Adults in the Far West Region of China
by: Shuxia Guo, et al.
Published: (2015-12-01)

Associations of cholesteryl ester transfer protein (CETP) gene variants with pituitary adenoma
by: Agne Sidaraite, et al.
Published: (2020-06-01)

A review of CETP and its relation to atherosclerosis
by: Greetje J. de Grooth, et al.
Published: (2004-11-01)

Low‐density lipoprotein receptor is required for cholesteryl ester transfer protein to regulate triglyceride metabolism in both male and female mice
by: Brian T. Palmisano, et al.
Published: (2021-02-01)

In vitro and in vivo human metabolism and pharmacokinetics of S‐ and R‐praziquantel
by: Nyasha Nicole Kapungu, et al.
Published: (2020-08-01)

Wolman disease/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in mice*
by: Hong Du, et al.
Published: (2008-08-01)

The Presence of Cholesteryl Ester Transfer Protein (CETP) in Endothelial Cells Generates Vascular Oxidative Stress and Endothelial Dysfunction
by: Amarylis C. B. A. Wanschel, et al.
Published: (2021-01-01)

New molecular insights into CETP structure and function: a review
by: M. Arthur Charles, et al.
Published: (2012-08-01)

Constitutive inhibition of plasma CETP by apolipoprotein C1 is blunted in dyslipidemic patients with coronary artery disease[S]
by: Xavier Pillois, et al.
Published: (2012-06-01)

Cholesteryl esterase and cholesteryl ester pools in corpus luteum
by: J.R.T. Coutts, et al.
Published: (1968-09-01)

Simultaneous transfer of cholesterol, triglycerides, and phospholipids to high-density lipoprotein in aging subjects with or without coronary artery disease
by: Carolina H. M Azevedo, et al.
Published: (2011-01-01)

Impact of drug distribution into adipose on tissue function: The cholesteryl ester transfer protein (CETP) inhibitor anacetrapib as a test case
by: Douglas G. Johns, et al.
Published: (2019-12-01)

Amélioration de la prédiction de la clairance métabolique via l’utilisation de modèles hépatiques innovants
by: Da Silva, Franck
Published: (2018)

Quinoline-3-carboxamide Derivatives as Potential Cholesteryl Ester Transfer Protein Inhibitors
by: Jing-Kang Shen, et al.
Published: (2012-05-01)

Cholesteryl ester transfer protein and hyperalphalipoproteinemia in Caucasianss⃞
by: Wim A. van der Steeg, et al.
Published: (2007-03-01)

Association between Six CETP Polymorphisms and Metabolic Syndrome in Uyghur Adults from Xinjiang, China
by: Huixian Hou, et al.
Published: (2017-06-01)

Influence of dietary fatty acid composition on the relationship between CETP activity and plasma lipoproteins in monkeys
by: Yuichi Fusegawa, et al.
Published: (2001-11-01)

Antisense oligonucleotide inhibition of cholesteryl ester transfer protein enhances RCT in hyperlipidemic, CETP transgenic, LDLr-/- mice
by: Thomas A. Bell, III, et al.
Published: (2013-10-01)

Human plasma CETP deficiency: identification of a novel mutation in exon 9 of the CETP gene in a Caucasian subject from North America
by: Evelyn M. Teh, et al.
Published: (1998-02-01)

Expression of simian CETP in normolipidemic Fisher rats has a profound effect on large sized apoE-containing HDL
by: Zoulika Zak, et al.
Published: (2002-12-01)

Influence of insulin sensitivity and the TaqIB cholesteryl ester transfer protein gene polymorphism on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities and their response to hyperinsulinemia in non-diabetic men
by: S.C. Riemens, et al.
Published: (1999-08-01)

Sources of eicosanoid precursor fatty acid pools in tissues
by: Li Zhou, et al.
Published: (2001-10-01)

Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure
by: Guoqing Cao, et al.
Published: (2011-12-01)

Pharmacodynamics and pharmacokinetics of snake antivenom
by: Bhagya Nikapitiya, et al.
Published: (2018-06-01)

Sulodexide. Pharmacokinetics, pharmacodynamics, and mechanism of action
by: Luca Masotti
Published: (2015-10-01)

Cefazolin in dog: preliminary results for pharmacokinetic and pharmacodynamic parameters
by: Federica Di Cesare
Published: (2016-06-01)

Pharmacokinetic and pharmacodynamic modeling of oral mitiglinide on glucose lowering in healthy Chinese volunteers
by: Shijia Liu, et al.
Published: (2017-07-01)

Population pharmacokinetics and pharmacodynamics of pyronaridine
by: Methaneethorn, Janthima
Published: (2013)

Cooperation between hepatic cholesteryl ester hydrolase and scavenger receptor BI for hydrolysis of HDL-CE
by: Quan Yuan, et al.
Published: (2013-11-01)

Pharmacodynamics of Five Anthraquinones (Aloe-emodin, Emodin, Rhein, Chysophanol, and Physcion) and Reciprocal Pharmacokinetic Interaction in Rats with Cerebral Ischemia
by: Rong-Rong Li, et al.
Published: (2019-05-01)